
From the CEC Smart Brief:
The Food and Drug Administration Thursday approved the once-a-day Daytrana skin patch, which delivers a generic version of Ritalin, for treatment of children ages 6 to 12 with ADHD. Experts say the patch will particularly help children who have trouble taking pills. Reuters (4/7)
No comments:
Post a Comment